Imipramine Is an Orally Active Drug against Both Antimony Sensitive and…

The following two tabs change content below.
PLoSNTDs

PLoSNTDs

PLOS Neglected Tropical Diseases is the first open-access journal devoted to the world's most neglected tropical diseases (NTDs), such as elephantiasis, river blindness, leprosy, hookworm, schistosomiasis, and African sleeping sickness. Links to PLoSNTD content is shared via GHHub using the Creative Commons. http://www.plosntds.org/

by Sandip Mukherjee, Budhaditya Mukherjee, Rupkatha Mukhopadhyay, Kshudiram Naskar, Shyam Sundar, Jean Claude Dujardin, Anjan Kumar Das, Syamal Roy Background In an endeavor to find an orally active and affordable antileishmanial drug, we tested the efficacy of a cationic amphiphilic drug, imipramine, commonly used for the treatment of depression in humans. The only available orally active antileishmanial drug is miltefosine with long half life and teratogenic potential limits patient compliance. Thus there is a genuine need for an orally active antileishmanial drug. Previously it was shown that imipramine, a tricyclic antidepressant alters the protonmotive force in promastigotes, but its in vivo efficacy was not reported.

Link to article:  

Imipramine Is an Orally Active Drug against Both Antimony Sensitive and…